Latest Insider Transactions at Xeris Biopharma Holdings, Inc. (XERS)
This section provides a real-time view of insider transactions for Xeris Biopharma Holdings, Inc. (XERS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Xeris Biopharma Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Xeris Biopharma Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 22
2024
|
Steven Pieper Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,483
+1.33%
|
$19,483
$1.55 P/Share
|
|
Aug 12
2024
|
John P. Schmid Director |
BUY
Open market or private purchase
|
Indirect |
4,515
+15.19%
|
$9,030
$2.25 P/Share
|
|
Aug 09
2024
|
John P. Schmid Director |
BUY
Open market or private purchase
|
Indirect |
4,285
+17.16%
|
$8,570
$2.37 P/Share
|
|
Aug 01
2024
|
Kevin Mc Culloch Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+8.56%
|
-
|
|
Aug 01
2024
|
John Patrick Shannon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+9.36%
|
-
|
|
Jul 28
2024
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,767
-1.03%
|
$29,534
$2.61 P/Share
|
|
Jun 05
2024
|
Dawn Halkuff Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+31.75%
|
-
|
|
Jun 05
2024
|
Garheng Kong Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+23.35%
|
-
|
|
Jun 05
2024
|
Marla Persky Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+31.75%
|
-
|
|
Jun 05
2024
|
John Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+5.31%
|
-
|
|
Jun 05
2024
|
Barbara Jean Anne Bormann Kennedy Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+31.75%
|
-
|
|
Jun 05
2024
|
Jeffrey W Sherman Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+23.32%
|
-
|
|
Jun 05
2024
|
Ricki Louise Fairley Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+27.03%
|
-
|
|
Jun 05
2024
|
John P. Schmid Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+30.65%
|
-
|
|
May 10
2024
|
John P. Schmid Director |
BUY
Open market or private purchase
|
Indirect |
5,400
+24.77%
|
$5,400
$1.91 P/Share
|
|
Mar 18
2024
|
John Johnson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
215,600
+22.3%
|
$215,600
$1.99 P/Share
|
|
Mar 15
2024
|
Jeffrey W Sherman Director |
BUY
Other acquisition or disposition
|
Direct |
6,502
+5.38%
|
-
|
|
Mar 15
2024
|
Garheng Kong Director |
BUY
Other acquisition or disposition
|
Direct |
6,474
+5.37%
|
-
|
|
Mar 15
2024
|
John Johnson Director |
BUY
Other acquisition or disposition
|
Direct |
89,571
+9.63%
|
-
|
|
Mar 14
2024
|
John P. Schmid Director |
BUY
Open market or private purchase
|
Indirect |
4,500
+29.03%
|
$9,000
$2.16 P/Share
|
|
Jan 31
2024
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
110,750
-7.16%
|
$221,500
$2.46 P/Share
|
|
Jan 31
2024
|
Kenneth Erland Johnson Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,131
-3.9%
|
$30,262
$2.46 P/Share
|
|
Jan 31
2024
|
Beth Hecht Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
45,909
-3.22%
|
$91,818
$2.46 P/Share
|
|
Jan 31
2024
|
John Patrick Shannon Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
110,750
-4.9%
|
$221,500
$2.46 P/Share
|
|
Jan 31
2024
|
Beth Hecht Officer |
BUY
Grant, award, or other acquisition
|
Direct |
750,000
+32.54%
|
-
|
|
Jan 31
2024
|
Kenneth Erland Johnson Officer |
BUY
Grant, award, or other acquisition
|
Direct |
175,000
+28.14%
|
-
|
|
Jan 31
2024
|
John Patrick Shannon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
750,000
+25.79%
|
-
|
|
Jan 31
2024
|
Steven Pieper Officer |
BUY
Grant, award, or other acquisition
|
Direct |
450,000
+21.67%
|
-
|
|
Jan 31
2024
|
Paul R Edick Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500,000
+28.37%
|
-
|
|
Jan 29
2024
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,379
-0.28%
|
$8,758
$2.66 P/Share
|
|
Jan 29
2024
|
Kenneth Erland Johnson Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,747
-2.69%
|
$21,494
$2.66 P/Share
|
|
Jan 29
2024
|
Beth Hecht Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,675
-1.36%
|
$39,350
$2.66 P/Share
|
|
Jan 29
2024
|
John Patrick Shannon Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
22,150
-0.97%
|
$44,300
$2.66 P/Share
|
|
Jan 03
2024
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,067
-1.46%
|
$46,134
$2.24 P/Share
|
|
Jan 03
2024
|
Kenneth Erland Johnson Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,400
-3.01%
|
$24,800
$2.24 P/Share
|
|
Jan 03
2024
|
Beth Hecht Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,488
-2.26%
|
$66,976
$2.24 P/Share
|
|
Jan 03
2024
|
John Patrick Shannon Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
40,834
-1.76%
|
$81,668
$2.24 P/Share
|
|
Nov 27
2023
|
Jeffrey W Sherman Director |
BUY
Open market or private purchase
|
Indirect |
5,400
+50.0%
|
$5,400
$1.87 P/Share
|
|
Nov 20
2023
|
Dawn Halkuff Director |
BUY
Open market or private purchase
|
Indirect |
5,410
+50.0%
|
$5,410
$1.84 P/Share
|
|
Nov 20
2023
|
Steven Pieper Officer |
BUY
Open market or private purchase
|
Direct |
28,000
+2.32%
|
$28,000
$1.95 P/Share
|
|
Nov 17
2023
|
John Patrick Shannon Jr Director |
BUY
Open market or private purchase
|
Direct |
30,769
+2.14%
|
$30,769
$1.64 P/Share
|
|
Nov 16
2023
|
John P. Schmid Director |
BUY
Open market or private purchase
|
Indirect |
6,500
+50.0%
|
$6,500
$1.51 P/Share
|
|
Nov 14
2023
|
Marla Persky Director |
BUY
Open market or private purchase
|
Indirect |
6,370
+50.0%
|
$6,370
$1.58 P/Share
|
|
Aug 09
2023
|
Paul R Edick Director |
BUY
Open market or private purchase
|
Direct |
10,000
+0.44%
|
$20,000
$2.38 P/Share
|
|
Jul 28
2023
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,200
-0.64%
|
$20,400
$2.53 P/Share
|
|
Jun 07
2023
|
Garheng Kong Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+28.3%
|
-
|
|
Jun 07
2023
|
Barbara Jean Anne Bormann Kennedy Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+42.5%
|
-
|
|
Jun 07
2023
|
John P. Schmid Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+40.22%
|
-
|
|
Jun 07
2023
|
Marla Persky Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+42.5%
|
-
|
|
Jun 07
2023
|
Dawn Halkuff Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+42.5%
|
-
|